Immunotherapy Response Monitoring in Melanoma

October 12th 2021

John Kirkwood, MD, PhD, discusses the use of immunotherapy as a treatment option for melanoma, including ctDNA, and how to properly monitor responses.

Updates in Therapies of Relapse/Refractory Follicular Lymphoma

September 7th 2021

Connie Batlevi, MD, PhD, explains the treatment options for relapsed/refractory follicular lymphoma and discusses a recent drug approval.

Updates in Therapies of Relapsed and Refractory Follicular Lymphoma

July 6th 2021

Javier L. Munoz, MD, MS, FACP, explains the treatment options for relapsed/refractory follicular lymphoma and provides insight into a recent clinical trial.

NCCN Guideline Updates in HR+ Breast Cancer: Focus on Extended Adjuvant Therapy

June 28th 2021

Recommendations for utilizing genomic testing to aid in treatment decisions for early-stage HR+ breast cancer based on updates to the NCCN guidelines.

Management of Relapsed/Refractory Follicular Lymphoma

May 12th 2021

Sameh Gaballa, MD, reviews the treatment options for relapsed/refractory follicular lymphoma and future treatment options.

Updates in the Management of Extensive-Stage Small Cell Lung Cancer

May 10th 2021

Considerations for adding immunotherapy to the armamentarium for frontline treatment of extensive-stage small cell lung cancer.

Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer

May 7th 2021

The current role of genomic testing in HR+ breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting.

MRD and Decision-Making in Early Stage Colorectal Cancer

March 26th 2021

Experts focus in on optimizing the use of minimal residual disease as a tool to guide decision making in the adjuvant setting for patients at risk for recurrence with colorectal cancer.

Therapeutic Advancements in Multiple Myeloma

January 21st 2021

CancerNetwork spoke with Kenneth C. Anderson, MD, about treatment advances in myeloma - from smoldering, newly diagnosed, and relapsed/refractory multiple myeloma.

Assessing the Small Cell Lung Cancer Treatment Landscape

January 13th 2021

CancerNetwork spoke with Wade T. Iams, MD, about treatment options available and being evaluated in small cell lung cancer.